Clinical Trials Browser

Phase 1 × Adenocarcinoma × Irinotecan × Clear all

Adenocarcinoma

NCT04299880 2023-11-08

Rollover Study to Provide Continued Access to Napabucasin for Patients Enrolled in Boston Biomedical-sponsored Protocols

Adenocarcinoma, Digestive System Diseases, Digestive System Neoplasms, Neoplasms, Neoplasms by Site, Neoplasms, Glandular and Epithelial, Pancreatic Neoplasms

NCT01383538 2017-08-08

FOLFIRINOX Plus IPI-926 for Advanced Pancreatic Adenocarcinoma

Phase 1 Completed

15 enrolled

Gastrointestinal

Adenocarcinoma, Neoplasms, Pancreatic Neoplasms

NCT00507091 2016-08-25

Phase I Irinotecan, 5-Fluorouracil and Leucovorin Combination

Phase 1 Completed

24 enrolled

Tumor-Agnostic

Adenocarcinoma, Neoplasm Metastasis

NCT02283359 2016-01-15

Selinexor in Combination With Irinotecan in Adenocarcinoma of Stomach and Distal Esophagus

Phase 1 Terminated

3 enrolled

Gastrointestinal

Adenocarcinoma, Carcinoma, Esophageal Neoplasms, Neoplasm Metastasis, Recurrence, Stomach Neoplasms

NCT00183859 2014-05-22

Clinical and Pharmacokinetic Trial of Intra-Abdominal Irinotecan

Phase 1 Completed

42 enrolled

Gastrointestinal

Adenocarcinoma, Stomach Neoplasms

Clinical Trials

I-FLOAT

Rollover Study to Provide Continued Access to Napabucasin for Patients Enrolled in Boston Biomedical-sponsored Protocols

FOLFIRINOX Plus IPI-926 for Advanced Pancreatic Adenocarcinoma

Phase I Irinotecan, 5-Fluorouracil and Leucovorin Combination

Selinexor in Combination With Irinotecan in Adenocarcinoma of Stomach and Distal Esophagus

Clinical and Pharmacokinetic Trial of Intra-Abdominal Irinotecan